Form 4 for GANX Gain Therapeutics, Inc.
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-19 · accession 0001415889-22-005317 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E | 2022-05-19 | 2022-05-19 | GANX | Calabrese Salvatore | CFO | P - Purchase | $8,100.00 | +3,000 | 8,100 | +59% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-19 | P | A | 3,000 | $8,100.00 | 8,100 | D | — | — |